endocrine and metabolic disorders
Overview of Thyroid Function
Laboratory Testing of Thyroid Function
TSH measurement is the best means of determining thyroid dysfunction (see table Results of Thyroid Function Tests in Various Clinical Situations ). Normal results essentially rule out Changes in the serum TSH level in the presence of normal serum T4, free T4, serum T3, and free T3 levels define the syndromes of Management of subclinical hyperthyroidism (low serum TSH) and Total serum T4 is a measure of bound and free hormone. Changes in levels of thyroid hormone–binding serum proteins produce corresponding changes in total T4, even though levels of physiologically active free T4 are unchanged. Thus, a patient may be physiologically normal but have an abnormal total serum T4 level. Free T4 in the serum can be measured directly, avoiding the pitfalls of interpreting total T4 levels. Free T4 index is a calculated value that corrects total T4 for the effects of varying amounts of thyroid hormone–binding serum proteins and thus gives an estimate of free T4 when total T4 is measured. The thyroid hormone–binding ratio or T4 resin uptake is used to estimate protein binding. Free T4 index is readily available and compares well with direct measurement of free T4. Total serum T3 and free T3 can also be measured. Because T3 is tightly bound to TBG (although 10 times less so than T4), total serum T3 levels are influenced by alterations in serum TBG level and by drugs that affect binding to TBG. Free T3 levels in the serum are measured by the same direct and indirect methods (free T3 index) described for T4 and are used mainly for evaluating thyrotoxicosis. oral contraceptive use, and in the Overview of Acute Viral Hepatitis . TBG may also be increased by an X-linked mutation in the gene encoding TBG. It is most commonly decreased by illnesses that reduce hepatic protein synthesis, use of anabolic steroids, the nephrotic syndrome, and excessive corticosteroid use. Large doses of certain drugs, such as Autoantibodies to thyroid peroxidase are present in almost all patients with Hashimoto Thyroiditis (some of whom also have autoantibodies to thyroglobulin) and in most patients with Graves disease. These autoantibodies are markers of autoimmune disease but probably do not cause disease. However, an autoantibody directed against the thyroid-stimulating hormone receptor on the thyroid follicular cell is responsible for the hyperthyroidism in Graves disease. Antibodies against T4 and T3 may be found in patients with autoimmune thyroid disease and may affect T4 and T3 measurements but are rarely clinically significant. The thyroid is the only source of thyroglobulin, which is readily detectable in the serum of healthy people and is usually elevated in patients with nontoxic or toxic goiter. The principal use of serum thyroglobulin measurement is in evaluating patients after near-total or total thyroidectomy (with or without iodine-131 ablation) for differentiated thyroid cancer. Normal or elevated serum thyroglobulin values indicate the presence of residual normal or cancerous thyroid tissue in patients receiving TSH-suppressive doses oflevothyroxineor after withdrawal oflevothyroxine. However, thyroglobulin antibodies interfere with thyroglobulin measurement. Screening for thyroid disease is recommended for all newborns to detect Congenital hypothyroidism , which may impair normal development if untreated. Routine screening for asymptomatic adults including pregnant women without known risk factors for thyroid disease is not recommended due to insufficient evidence of a benefit. For patients with risk factors, the serum TSH should be measured and is the best test to screen for both hyper- and hypothyroidism. Because of the increased prevalence of Subclinical hypothyroidism in older adults, some authorities recommend screening on an annual basis for those 